-
2
-
-
42949163491
-
Mechanisms of hepatic fibrogenesis
-
Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669
-
(2008)
Gastroenterology
, vol.134
, pp. 1655-1669
-
-
Friedman, S.L.1
-
3
-
-
42949086433
-
Cellular and molecular mechanisms of liver injury
-
Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-1654
-
(2008)
Gastroenterology
, vol.134
, pp. 1641-1654
-
-
Malhi, H.1
Gores, G.J.2
-
4
-
-
35948954244
-
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
-
Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172
-
(2008)
Physiol Rev
, vol.88
, pp. 125-172
-
-
Friedman, S.L.1
-
5
-
-
0032146551
-
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
-
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549
-
(1998)
J Clin Invest
, vol.102
, pp. 538-549
-
-
Iredale, J.P.1
Benyon, R.C.2
Pickering, J.3
McCullen, M.4
Northrop, M.5
Pawley, S.6
Hovell, C.7
Arthur, M.J.8
-
6
-
-
0037221910
-
Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors
-
Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003; 124: 147-159
-
(2003)
Gastroenterology
, vol.124
, pp. 147-159
-
-
Yang, C.1
Zeisberg, M.2
Mosterman, B.3
Sudhakar, A.4
Yerramalla, U.5
Holthaus, K.6
Xu, L.7
Eng, F.8
Afdhal, N.9
Kalluri, R.10
-
7
-
-
0026527581
-
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis
-
Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 19-27
-
(1992)
J Clin Invest
, vol.89
, pp. 19-27
-
-
Bachem, M.G.1
Meyer, D.2
Melchior, R.3
Sell, K.M.4
Gressner, A.M.5
-
8
-
-
20044385758
-
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
-
Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 2005; 102: 3389-3394
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 3389-3394
-
-
Campbell, J.S.1
Hughes, S.D.2
Gilbertson, D.G.3
Palmer, T.E.4
Holdren, M.S.5
Haran, A.C.6
Odell, M.M.7
Bauer, R.L.8
Ren, H.P.9
Haugen, H.S.10
Yeh, M.M.11
Fausto, N.12
-
9
-
-
33847622043
-
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
-
Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007; 39: 695-714
-
(2007)
Int J Biochem Cell Biol
, vol.39
, pp. 695-714
-
-
Muddu, A.K.1
Guha, I.N.2
Elsharkawy, A.M.3
Mann, D.A.4
-
10
-
-
39149125148
-
Recent developments in targeting liver fibrosis
-
Iredale J. Recent developments in targeting liver fibrosis. Clin Med 2008; 8: 29-31
-
(2008)
Clin Med
, vol.8
, pp. 29-31
-
-
Iredale, J.1
-
11
-
-
34047121535
-
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
-
Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955-975
-
(2007)
J Hepatol
, vol.46
, pp. 955-975
-
-
Hemmann, S.1
Graf, J.2
Roderfeld, M.3
Roeb, E.4
-
12
-
-
0028906431
-
Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
-
Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995; 21: 787-795
-
(1995)
Hepatology
, vol.21
, pp. 787-795
-
-
Takahara, T.1
Furui, K.2
Funaki, J.3
Nakayama, Y.4
Itoh, H.5
Miyabayashi, C.6
Sato, H.7
Seiki, M.8
Ooshima, A.9
Watanabe, A.10
-
13
-
-
0345643514
-
Regulation of matrix metalloproteinase expression in tumor invasion
-
Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792
-
(1999)
FASEB J
, vol.13
, pp. 781-792
-
-
Westermarck, J.1
Kähäri, V.M.2
-
14
-
-
0034767501
-
Transforming growth factor beta and the liver
-
Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001; 34: 859-867
-
(2001)
Hepatology
, vol.34
, pp. 859-867
-
-
Bissell, D.M.1
Roulot, D.2
George, J.3
-
15
-
-
33744538682
-
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets
-
Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76-99
-
(2006)
J Cell Mol Med
, vol.10
, pp. 76-99
-
-
Gressner, A.M.1
Weiskirchen, R.2
-
16
-
-
0036690114
-
Drugs targeting the renin-angiotensin-aldosterone system
-
Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 2002; 1: 621-636
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 621-636
-
-
Zaman, M.A.1
Oparil, S.2
Calhoun, D.A.3
-
17
-
-
0037667643
-
Newly recognized components of the renin-angiotensin system: Potential roles in cardiovascular and renal regulation
-
Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24: 261-271
-
(2003)
Endocr Rev
, vol.24
, pp. 261-271
-
-
Carey, R.M.1
Siragy, H.M.2
-
18
-
-
0036563250
-
Biological properties of the angiotensin peptides other than angiotensin II: Implications for hypertension and cardiovascular diseases
-
Cesari M, Rossi GP, Pessina AC. Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J Hypertens 2002; 20: 793-799
-
(2002)
J Hypertens
, vol.20
, pp. 793-799
-
-
Cesari, M.1
Rossi, G.P.2
Pessina, A.C.3
-
20
-
-
33646579401
-
-
Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ, Santos RA. The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem 2006; 6: 603-609
-
Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ, Santos RA. The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem 2006; 6: 603-609
-
-
-
-
21
-
-
42649115768
-
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
-
Santos RA, Ferreira AJ, Simões E Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93: 519-27
-
(2008)
Exp Physiol
, vol.93
, pp. 519-527
-
-
Santos, R.A.1
Ferreira, A.J.2
Simões, E.3
Silva, A.C.4
-
22
-
-
0038053724
-
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
-
Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9
-
(2000)
Circ Res
, vol.87
-
-
Donoghue, M.1
Hsieh, F.2
Baronas, E.3
Godbout, K.4
Gosselin, M.5
Stagliano, N.6
Donovan, M.7
Woolf, B.8
Robison, K.9
Jeyaseelan, R.10
Breitbart, R.E.11
Acton, S.12
-
23
-
-
0034721906
-
A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
-
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243
-
(2000)
J Biol Chem
, vol.275
, pp. 33238-33243
-
-
Tipnis, S.R.1
Hooper, N.M.2
Hyde, R.3
Karran, E.4
Christie, G.5
Turner, A.J.6
-
24
-
-
0037195251
-
Just the beginning: Novel functions for angiotensin-converting enzymes
-
Eriksson U, Danilczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 2002; 12: R745-R752
-
(2002)
Curr Biol
, vol.12
-
-
Eriksson, U.1
Danilczyk, U.2
Penninger, J.M.3
-
25
-
-
6344246036
-
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
-
Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004; 383: 45-51
-
(2004)
Biochem J
, vol.383
, pp. 45-51
-
-
Rice, G.I.1
Thomas, D.A.2
Grant, P.J.3
Turner, A.J.4
Hooper, N.M.5
-
26
-
-
0037478671
-
-
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263
-
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263
-
-
-
-
27
-
-
0016201632
-
Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II
-
Khosla MC, Hall MM, Smeby RR, Bumpus FM. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II. J Med Chem 1974; 17: 1156-1160
-
(1974)
J Med Chem
, vol.17
, pp. 1156-1160
-
-
Khosla, M.C.1
Hall, M.M.2
Smeby, R.R.3
Bumpus, F.M.4
-
28
-
-
0035459470
-
Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels
-
Souza Dos Santos RA, Passaglio KT, Pesquero JB, Bader M, Simões E Silva AC. Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels. Hypertension 2001; 38: 660-664
-
(2001)
Hypertension
, vol.38
, pp. 660-664
-
-
Souza Dos Santos, R.A.1
Passaglio, K.T.2
Pesquero, J.B.3
Bader, M.4
Simões, E.5
Silva, A.C.6
-
30
-
-
0026409556
-
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat
-
Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991; 18: 763-773
-
(1991)
Hypertension
, vol.18
, pp. 763-773
-
-
Campbell, D.J.1
Lawrence, A.C.2
Towrie, A.3
Kladis, A.4
Valentijn, A.J.5
-
31
-
-
0037409312
-
The renin-angiotensin and the kallikreinkinin systems
-
Campbell DJ. The renin-angiotensin and the kallikreinkinin systems. Int J Biochem Cell Biol 2003; 35: 784-791
-
(2003)
Int J Biochem Cell Biol
, vol.35
, pp. 784-791
-
-
Campbell, D.J.1
-
32
-
-
0029974215
-
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension
-
Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 1996; 14: 799-805
-
(1996)
J Hypertens
, vol.14
, pp. 799-805
-
-
Luque, M.1
Martin, P.2
Martell, N.3
Fernandez, C.4
Brosnihan, K.B.5
Ferrario, C.M.6
-
33
-
-
0036669202
-
Angiotensin-(1-7) in normal and preeclamptic pregnancy
-
Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002; 18: 239-245
-
(2002)
Endocrine
, vol.18
, pp. 239-245
-
-
Merrill, D.C.1
Karoly, M.2
Chen, K.3
Ferrario, C.M.4
Brosnihan, K.B.5
-
34
-
-
34047163936
-
The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes
-
Nogueira AI, Souza Santos RA, Simões E Silva AC, Cabral AC, Vieira RL, Drumond TC, Machado LJ, Freire CM, Ribeiro-Oliveira A Jr. The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes. Regul Pept 2007; 141: 55-60
-
(2007)
Regul Pept
, vol.141
, pp. 55-60
-
-
Nogueira, A.I.1
Souza Santos, R.A.2
Simões, E.3
Silva, A.C.4
Cabral, A.C.5
Vieira, R.L.6
Drumond, T.C.7
Machado, L.J.8
Freire, C.M.9
Ribeiro-Oliveira Jr., A.10
-
35
-
-
33751254359
-
-
Simões e Silva AC, Diniz JS, Pereira RM, Pinheiro SV, Santos RA. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease. Pediatr Res 2006; 60: 734-739
-
Simões e Silva AC, Diniz JS, Pereira RM, Pinheiro SV, Santos RA. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease. Pediatr Res 2006; 60: 734-739
-
-
-
-
36
-
-
3242707890
-
The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1-7) in essential hypertension
-
Simões E Silva AC, Diniz JS, Regueira Filho A, Santos RA. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension. J Pediatr 2004; 145: 93-98
-
(2004)
J Pediatr
, vol.145
, pp. 93-98
-
-
Simões, E.1
Silva, A.C.2
Diniz, J.S.3
Regueira Filho, A.4
Santos, R.A.5
-
37
-
-
0032732540
-
State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle
-
Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension 1999; 34: 950-957
-
(1999)
Hypertension
, vol.34
, pp. 950-957
-
-
Tallant, E.A.1
Diz, D.I.2
Ferrario, C.M.3
-
38
-
-
0033607368
-
Opposing actions of angiotensins on angiogenesis
-
Machado RD, Santos RA, Andrade SP. Opposing actions of angiotensins on angiogenesis. Life Sci 2000; 66: 67-76
-
(2000)
Life Sci
, vol.66
, pp. 67-76
-
-
Machado, R.D.1
Santos, R.A.2
Andrade, S.P.3
-
39
-
-
18944403331
-
Cardiovascular actions of angiotensin-(1-7)
-
Ferreira AJ, Santos RA. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 2005; 38: 499-507
-
(2005)
Braz J Med Biol Res
, vol.38
, pp. 499-507
-
-
Ferreira, A.J.1
Santos, R.A.2
-
40
-
-
8844265279
-
Inhibition of human lung cancer cell growth by angiotensin-(1-7)
-
Gallagher PE, Tallant EA. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004; 25: 2045-2052
-
(2004)
Carcinogenesis
, vol.25
, pp. 2045-2052
-
-
Gallagher, P.E.1
Tallant, E.A.2
-
42
-
-
25444473110
-
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor
-
Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 2005; 289: H1560-H1566
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
-
-
Tallant, E.A.1
Ferrario, C.M.2
Gallagher, P.E.3
-
43
-
-
11244253741
-
Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat
-
Langeveld B, van Gilst WH, Tio RA, Zijlstra F, Roks AJ. Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. Hypertension 2005; 45: 138-141
-
(2005)
Hypertension
, vol.45
, pp. 138-141
-
-
Langeveld, B.1
van Gilst, W.H.2
Tio, R.A.3
Zijlstra, F.4
Roks, A.J.5
-
44
-
-
0141893551
-
Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)
-
Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 2003; 42: 574-579
-
(2003)
Hypertension
, vol.42
, pp. 574-579
-
-
Tallant, E.A.1
Clark, M.A.2
-
46
-
-
20244388129
-
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor
-
Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, Schultheiss HP, Walther T. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 2005; 111: 1806-1813
-
(2005)
Circulation
, vol.111
, pp. 1806-1813
-
-
Kostenis, E.1
Milligan, G.2
Christopoulos, A.3
Sanchez-Ferrer, C.F.4
Heringer-Walther, S.5
Sexton, P.M.6
Gembardt, F.7
Kellett, E.8
Martini, L.9
Vanderheyden, P.10
Schultheiss, H.P.11
Walther, T.12
-
47
-
-
0018915843
-
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis
-
Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-Lopez F, Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92-99
-
(1980)
Gastroenterology
, vol.78
, pp. 92-99
-
-
Bosch, J.1
Arroyo, V.2
Betriu, A.3
Mas, A.4
Carrilho, F.5
Rivera, F.6
Navarro-Lopez, F.7
Rodes, J.8
-
49
-
-
0029131135
-
Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis
-
Aliaga L, Zozoya JM, Omar M, Mediavilla JD, Prieto J. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis. Acta Gastroenterol Belg 1995; 58: 213-221
-
(1995)
Acta Gastroenterol Belg
, vol.58
, pp. 213-221
-
-
Aliaga, L.1
Zozoya, J.M.2
Omar, M.3
Mediavilla, J.D.4
Prieto, J.5
-
50
-
-
0031949661
-
Hepatorenal syndrome: Definition, pathophysiology, clinical features and management
-
Bataller R, Sort P, Ginès P, Arroyo V. Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int Suppl 1998; 66: S47-S53
-
(1998)
Kidney Int Suppl
, vol.66
-
-
Bataller, R.1
Sort, P.2
Ginès, P.3
Arroyo, V.4
-
51
-
-
0037579415
-
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis
-
Girgrah N, Liu P, Collier J, Blendis L, Wong F. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis. Gut 2000; 46: 114-120
-
(2000)
Gut
, vol.46
, pp. 114-120
-
-
Girgrah, N.1
Liu, P.2
Collier, J.3
Blendis, L.4
Wong, F.5
-
52
-
-
0034044918
-
Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites
-
Lee JK, Hsieh JF, Tsai SC, Ho YJ, Kao CH. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites. Hepatogastroenterology 2000; 47: 767-770
-
(2000)
Hepatogastroenterology
, vol.47
, pp. 767-770
-
-
Lee, J.K.1
Hsieh, J.F.2
Tsai, S.C.3
Ho, Y.J.4
Kao, C.H.5
-
53
-
-
0034120267
-
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
-
Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000; 118: 1149-1156
-
(2000)
Gastroenterology
, vol.118
, pp. 1149-1156
-
-
Bataller, R.1
Ginès, P.2
Nicolás, J.M.3
Görbig, M.N.4
Garcia-Ramallo, E.5
Gasull, X.6
Bosch, J.7
Arroyo, V.8
Rodés, J.9
-
54
-
-
0034961836
-
Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis
-
Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001; 121: 148-155
-
(2001)
Gastroenterology
, vol.121
, pp. 148-155
-
-
Jonsson, J.R.1
Clouston, A.D.2
Ando, Y.3
Kelemen, L.I.4
Horn, M.J.5
Adamson, M.D.6
Purdie, D.M.7
Powell, E.E.8
-
55
-
-
0034802566
-
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats
-
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001; 34: 745-750
-
(2001)
Hepatology
, vol.34
, pp. 745-750
-
-
Yoshiji, H.1
Kuriyama, S.2
Yoshii, J.3
Ikenaka, Y.4
Noguchi, R.5
Nakatani, T.6
Tsujinoue, H.7
Fukui, H.8
-
56
-
-
21844457440
-
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
-
Yang L, Bataller R, Dulyx J, Coffman TM, Ginès P, Rippe RA, Brenner DA. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 2005; 43: 317-323
-
(2005)
J Hepatol
, vol.43
, pp. 317-323
-
-
Yang, L.1
Bataller, R.2
Dulyx, J.3
Coffman, T.M.4
Ginès, P.5
Rippe, R.A.6
Brenner, D.A.7
-
57
-
-
33745204406
-
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
-
Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Iwai M, Horiuchi M, Chayama K. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis. Biochem Biophys Res Commun 2006; 346: 658-664
-
(2006)
Biochem Biophys Res Commun
, vol.346
, pp. 658-664
-
-
Nabeshima, Y.1
Tazuma, S.2
Kanno, K.3
Hyogo, H.4
Iwai, M.5
Horiuchi, M.6
Chayama, K.7
-
58
-
-
0034849945
-
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
-
Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001; 35: 376-385
-
(2001)
J Hepatol
, vol.35
, pp. 376-385
-
-
Paizis, G.1
Gilbert, R.E.2
Cooper, M.E.3
Murthi, P.4
Schembri, J.M.5
Wu, L.L.6
Rumble, J.R.7
Kelly, D.J.8
Tikellis, C.9
Cox, A.10
Smallwood, R.A.11
Angus, P.W.12
-
59
-
-
0036830185
-
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver
-
Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002; 123: 1667-1676
-
(2002)
Gastroenterology
, vol.123
, pp. 1667-1676
-
-
Paizis, G.1
Cooper, M.E.2
Schembri, J.M.3
Tikellis, C.4
Burrell, L.M.5
Angus, P.W.6
-
60
-
-
17844403732
-
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats
-
Bataller R, Gäbele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005; 41: 1046-1055
-
(2005)
Hepatology
, vol.41
, pp. 1046-1055
-
-
Bataller, R.1
Gäbele, E.2
Parsons, C.J.3
Morris, T.4
Yang, L.5
Schoonhoven, R.6
Brenner, D.A.7
Rippe, R.A.8
-
61
-
-
0034975578
-
The hyperdynamic circulation in cirrhosis: An overview
-
Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 2001; 89: 221-231
-
(2001)
Pharmacol Ther
, vol.89
, pp. 221-231
-
-
Blendis, L.1
Wong, F.2
-
63
-
-
0036785218
-
Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice
-
Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002; 13: 2464-2477
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2464-2477
-
-
Yang, J.1
Dai, C.2
Liu, Y.3
-
64
-
-
0034100147
-
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
-
Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34
-
(2000)
Pharmacol Rev
, vol.52
, pp. 11-34
-
-
Kim, S.1
Iwao, H.2
-
66
-
-
0028786514
-
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril
-
Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269: F491-F499
-
(1995)
Am J Physiol
, vol.269
-
-
Burdmann, E.A.1
Andoh, T.F.2
Nast, C.C.3
Evan, A.4
Connors, B.A.5
Coffman, T.M.6
Lindsley, J.7
Bennett, W.M.8
-
67
-
-
0028233556
-
Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney
-
Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45: 1637-1647
-
(1994)
Kidney Int
, vol.45
, pp. 1637-1647
-
-
Kaneto, H.1
Morrissey, J.2
McCracken, R.3
Reyes, A.4
Klahr, S.5
-
68
-
-
0027252762
-
Type I collagen gene regulation and the molecular pathogenesis of cirrhosis
-
Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol 1993; 264: G589-G595
-
(1993)
Am J Physiol
, vol.264
-
-
Brenner, D.A.1
Westwick, J.2
Breindl, M.3
-
69
-
-
0024416580
-
Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis
-
Czaja MJ, Weiner FR, Takahashi S, Giambrone MA, van der Meide PH, Schellekens H, Biempica L, Zern MA. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 1989; 10: 795-800
-
(1989)
Hepatology
, vol.10
, pp. 795-800
-
-
Czaja, M.J.1
Weiner, F.R.2
Takahashi, S.3
Giambrone, M.A.4
van der Meide, P.H.5
Schellekens, H.6
Biempica, L.7
Zern, M.A.8
-
70
-
-
0033109090
-
TGF-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
-
Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, zum Büschenfelde KH, Blessing M. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999; 276: G1059-G1068
-
(1999)
Am J Physiol
, vol.276
-
-
Kanzler, S.1
Lohse, A.W.2
Keil, A.3
Henninger, J.4
Dienes, H.P.5
Schirmacher, P.6
Rose-John, S.7
zum Büschenfelde, K.H.8
Blessing, M.9
-
71
-
-
28144453548
-
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
-
Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005; 54: 1790-1796
-
(2005)
Gut
, vol.54
, pp. 1790-1796
-
-
Paizis, G.1
Tikellis, C.2
Cooper, M.E.3
Schembri, J.M.4
Lew, R.A.5
Smith, A.I.6
Shaw, T.7
Warner, F.J.8
Zuilli, A.9
Burrell, L.M.10
Angus, P.W.11
-
72
-
-
33947174603
-
-
Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da Costa Dias FL, Barcelos LS, Collares GB, Simões e Silva AC. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7). J Hepatol 2007; 46: 674-681
-
Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da Costa Dias FL, Barcelos LS, Collares GB, Simões e Silva AC. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7). J Hepatol 2007; 46: 674-681
-
-
-
-
73
-
-
34547410910
-
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
-
Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM, Angus PW. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007; 47: 387-395
-
(2007)
J Hepatol
, vol.47
, pp. 387-395
-
-
Herath, C.B.1
Warner, F.J.2
Lubel, J.S.3
Dean, R.G.4
Jia, Z.5
Lew, R.A.6
Smith, A.I.7
Burrell, L.M.8
Angus, P.W.9
-
74
-
-
49849093788
-
Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications
-
Lubel JS, Herath CB, Burrell LM, Angus PW. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol 2008; 23: 1327-1338
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 1327-1338
-
-
Lubel, J.S.1
Herath, C.B.2
Burrell, L.M.3
Angus, P.W.4
-
75
-
-
67651192493
-
Angiotensin 1-7, an alternative metabolite of the renin-angiotensin system, is upregulated in human liver disease and has antifibrotic activity in the bile duct ligated rat
-
Lond
-
Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Angiotensin 1-7, an alternative metabolite of the renin-angiotensin system, is upregulated in human liver disease and has antifibrotic activity in the bile duct ligated rat. Clin Sci (Lond) 2009
-
(2009)
Clin Sci
-
-
Lubel, J.S.1
Herath, C.B.2
Tchongue, J.3
Grace, J.4
Jia, Z.5
Spencer, K.6
Casley, D.7
Crowley, P.8
Sievert, W.9
Burrell, L.M.10
Angus, P.W.11
-
76
-
-
0036380902
-
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat
-
Ferrario CM, Averill DB, Brosnihan KB, Chappell MC, Iskandar SS, Dean RH, Diz DI. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int 2002; 62: 1349-1357
-
(2002)
Kidney Int
, vol.62
, pp. 1349-1357
-
-
Ferrario, C.M.1
Averill, D.B.2
Brosnihan, K.B.3
Chappell, M.C.4
Iskandar, S.S.5
Dean, R.H.6
Diz, D.I.7
-
77
-
-
2042529307
-
Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats
-
Maia LG, Ramos MC, Fernandes L, de Carvalho MH, Campagnole-Santos MJ, Souza dos Santos RA. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. J Cardiovasc Pharmacol 2004; 43: 685-691
-
(2004)
J Cardiovasc Pharmacol
, vol.43
, pp. 685-691
-
-
Maia, L.G.1
Ramos, M.C.2
Fernandes, L.3
de Carvalho, M.H.4
Campagnole-Santos, M.J.5
Souza dos Santos, R.A.6
-
78
-
-
0028061656
-
Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): Evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors
-
Santos RA, Campagnole-Santos MJ, Baracho NC, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues AR, Gropen Júnior C. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 1994; 35: 293-298
-
(1994)
Brain Res Bull
, vol.35
, pp. 293-298
-
-
Santos, R.A.1
Campagnole-Santos, M.J.2
Baracho, N.C.3
Fontes, M.A.4
Silva, L.C.5
Neves, L.A.6
Oliveira, D.R.7
Caligiorne, S.M.8
Rodrigues, A.R.9
Gropen Júnior, C.10
-
79
-
-
4644372221
-
-
Pinheiro SV, Simões e Silva AC, Sampaio WO, de Paula RD, Mendes EP, Bontempo ED, Pesquero JB, Walther T, Alenina N, Bader M, Bleich M, Santos RA. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension 2004; 44: 490-496
-
Pinheiro SV, Simões e Silva AC, Sampaio WO, de Paula RD, Mendes EP, Bontempo ED, Pesquero JB, Walther T, Alenina N, Bader M, Bleich M, Santos RA. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension 2004; 44: 490-496
-
-
-
|